According to the recent research report titled ‘Global Hexamethyldisilazane (HMDS) Market (Value, Volume) - Analysis By Application, By Type, By Region, By Country (2021 Edition): Market Insights and Forecast with Impact of COVID-19 (2021-2026)’, available with Market Study Report LLC, global hexamethyldisilazane (HMDS) market was valued at USD 202.32 million in 2020 and is expected to register robust CAGR over 2021-2026.
 

Product usage for semiconductor processing, and demand for pharmaceutical intermediate are driving global hexamethyldisilazane (HMDS) market growth.
 

Request sample copy of this Report: https://www.marketstudyreport.com/request-a-sample/3958918/
 

For the unversed, hexamethyldisilazane (HMDS) is an organosilicon compound utilized as a precursor or reagent to bases, and as a silylating agent in the production of antibiotics (Cefadroxil and Cefprozil) and antiretroviral medicines (ARVs like Lamivudine, Sofosbuvir, and Emtricitabine).
 

HMDS is employed as a functional group protecting agent, catalyst, and activator in pharmaceutical applications. It can be used to make cardiovascular drugs (Atorvastatin Calcium, Rosuvastatin, etc.), antibiotics drugs (Cefomycin, Penicillin, Amikacin, etc.), and nucleoside drugs (Capecitabine, Sofosbuvir, Lamivudine, Zidovudine, Cytarabine, and Fluorouracil).
 

The broad application areas like surface treatment, organic synthesis, and semiconductors are also important growth drivers for worldwide hexamethyldisilazane (HMDS) market. The compound is utilized in the electronics industry to produce rubbers, coatings, tailing agents, or as a semiconductor. It is also used in automotive care products as a sealant and an adhesive.
 

HDMS can be used to modify the surface of white carbon black powder and diatomaceous earth powder to enhance reinforcing, hydrophobicity, and tear resistance in surface treatment applications. It can increase the electrochemical and cycling performance of lithium-ion batteries in case of lithium battery electrolyte application. HMDS can be utilized as an anti-corrosion adhesion assistance agent for electronic cleaning agents, positive photoresist, and semiconductor photoresist owing to its high volatility and low impurity residue.
 

Geographically, North America is a major contributor to the overall industry remuneration, creditable to amplifying silicon vertical, growing healthcare sector, and presence of various large manufacturers in the region. Moreover, escalating demand for medical implantable devices on account of increasing cases of chronic cardiovascular diseases is adding to the regional industry expansion.
 

Leading organizations defining the competitive landscape of global hexamethyldisilazane (HMDS) marketplace are BRB International B.V., Chemcon Speciality Chemicals Ltd., Evonik Industries AG, Wacker Chemie AG, Shin-Etsu Chemical Co. Ltd., and DuPont de Nemours Inc.